GO:0051481 negative regulation of cytosolic calcium ion concentration: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051481 describes any biological process that lowers the concentration of free calcium ions in the cytosol, a critical signaling compartment [1,2].
• Cells achieve this through calcium buffering, sequestration into intracellular stores such as the endoplasmic reticulum and mitochondria, and extrusion across the plasma membrane [2,5].
• Key molecular players include ryanodine receptors (RYR1, RYR2, RYR3), inositol 1,4,5-trisphosphate receptors (ITPR1, ITPR2, ITPR3), sarco/endoplasmic reticulum Ca2+-ATPases (SERCA), plasma membrane Ca2+-ATPases (PMCA), Na+/Ca2+ exchangers (NCX), and calcium-binding proteins such as calmodulin and calmodulin-like domains [1,2,4,8].
• Dysregulation of cytosolic calcium ion concentration is linked to cardiovascular disease, neurodegeneration, and metabolic disorders [1,3,7].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise dissection of genes controlling cytosolic calcium [4,6].
• EDITGENE provides end-to-end CRISPR cell model and screening services to accelerate calcium signaling research [4,6].
Description
Calcium ions (Ca2+) are universal second messengers that control processes as diverse as muscle contraction, secretion, gene expression, and cell death [1,2]. The concentration of free Ca2+ in the cytosol is kept extremely low under resting conditions, typically around 100 nM, while the extracellular space and intracellular stores maintain concentrations three to four orders of magnitude higher [2,5]. This steep gradient is essential for rapid and reversible Ca2+ signaling. GO:0051481, negative regulation of cytosolic calcium ion concentration, refers to any process that decreases the concentration of calcium ions in the cytosol [1,2]. Such processes are fundamental for terminating Ca2+ signals, preventing cytotoxic Ca2+ overload, and shaping the spatial and temporal patterns of Ca2+ transients [2,5]. Researchers study this term to understand how cells maintain calcium homeostasis, how this homeostasis is disrupted in disease, and how it can be targeted therapeutically [1,3,7].
negative regulation of cytosolic calcium ion concentration At A Glance
| GO ID | GO:0051481 |
|---|---|
| GO term | negative regulation of cytosolic calcium ion concentration |
| Ontology | biological_process |
| Synonym | cytoplasmic calcium ion concentration reduction; cytosolic calcium ion concentration reduction; reduction of calcium ion concentration in cytoplasm; reduction of calcium ion concentration in cytosol; reduction of cytoplasmic calcium ion concentration; reduction of cytosolic calcium ion concentration |
| Major function | Decreases free Ca2+ in the cytosol to terminate or prevent Ca2+ signaling and toxicity |
| Key organelles | Endoplasmic reticulum, mitochondria, plasma membrane, Golgi apparatus |
| Key protein families | Ryanodine receptors, IP3 receptors, SERCA pumps, PMCA pumps, NCX exchangers, calmodulin and related Ca2+-binding proteins |
| Related processes | Calcium homeostasis, excitation-contraction coupling, store-operated calcium entry, apoptosis |
What Is GO:0051481?
GO:0051481 is a biological process term defined as any process that decreases the concentration of calcium ions in the cytosol. In practice, this includes mechanisms that buffer free Ca2+ via calcium-binding proteins, sequester Ca2+ into intracellular organelles such as the endoplasmic reticulum, mitochondria, and Golgi apparatus, or extrude Ca2+ across the plasma membrane through pumps and exchangers [1,2,5].
Why Is negative regulation of cytosolic calcium ion concentration Important in Cell Biology?
Maintaining low resting cytosolic Ca2+ is essential for cell survival and normal physiology. Negative regulation of cytosolic calcium ion concentration allows cells to recover from Ca2+ signals, prevents sustained Ca2+ overload that can trigger necrosis or apoptosis, and ensures that Ca2+-dependent processes such as muscle contraction and hormone secretion are tightly controlled [1,2,5]. Defects in this regulation contribute to cardiac arrhythmias, hypertension, neurodegeneration, and metabolic disorders [1,3,7].
• Prevents cytotoxic Ca2+ overload that can lead to cell death.
• Terminates Ca2+ signals to allow repeated rounds of excitation-contraction coupling in muscle [2,5].
• Shapes the amplitude and duration of Ca2+ transients in neurons and endocrine cells.
• Supports proper cardiac rhythm and contractility by regulating diastolic Ca2+ removal.
• Maintains endoplasmic reticulum Ca2+ stores for protein folding and signaling.
• Modulates gene expression through Ca2+-dependent transcription factors.
• Dysregulation is implicated in hypertension and vascular dysfunction.
• Provides targets for therapeutic intervention in heart failure and neurodegeneration [1,2].
• Essential for immune cell activation and chemotaxis.
• Key to understanding store-operated calcium entry and feedback regulation.
What Happens During negative regulation of cytosolic calcium ion concentration?
Calcium buffering by cytosolic proteins
In simple terms: Proteins inside the cell act like sponges that soak up calcium ions, keeping the free calcium level low.
Cytosolic calcium-binding proteins such as calmodulin and calmodulin-like domains rapidly bind free Ca2+, reducing its effective concentration and shaping the duration of Ca2+ signals. These buffers also participate in Ca2+-dependent inactivation of channels, providing negative feedback.
Sequestration into the endoplasmic reticulum
In simple terms: The cell's internal storage compartments pump calcium in, removing it from the main fluid of the cell.
Sarco/endoplasmic reticulum Ca2+-ATPases (SERCA pumps) actively transport Ca2+ from the cytosol into the endoplasmic reticulum lumen, lowering cytosolic Ca2+ and refilling stores [4,5]. This process is regulated by phospholamban and other accessory proteins.
Mitochondrial calcium uptake
In simple terms: Mitochondria act as temporary calcium sinks, taking up calcium when levels get too high.
The mitochondrial calcium uniporter (MCU) complex allows rapid Ca2+ uptake into the mitochondrial matrix, which reduces cytosolic Ca2+ transients and modulates cellular metabolism [1,2]. Mitochondrial Na+/Ca2+ exchangers subsequently release Ca2+ to maintain homeostasis.
Extrusion across the plasma membrane
In simple terms: Pumps and exchangers on the cell surface push calcium out of the cell entirely.
Plasma membrane Ca2+-ATPases (PMCA) and Na+/Ca2+ exchangers (NCX) transport Ca2+ out of the cell against its gradient, providing a long-term mechanism to lower cytosolic Ca2+ [1,5]. NCX activity is particularly important in excitable cells such as cardiac myocytes and neurons.
Feedback regulation of release channels
In simple terms: The channels that release calcium can shut themselves off when calcium levels get too high.
Ryanodine receptors (RYR) and inositol 1,4,5-trisphosphate receptors (ITPR) undergo Ca2+-dependent inactivation, which reduces further Ca2+ release from stores and thus contributes to negative regulation of cytosolic Ca2+ [2,4]. This feedback is critical for terminating Ca2+ waves and preventing overload.
Key Genes Involved in GO:0051481 negative regulation of cytosolic calcium ion concentration
The following genes encode proteins that directly participate in lowering cytosolic calcium ion concentration through buffering, sequestration, or extrusion.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RYR1 | Ryanodine receptor 1, releases Ca2+ from sarcoplasmic reticulum in skeletal muscle | Ca2+-dependent inactivation and feedback regulation |
| RYR2 | Ryanodine receptor 2, cardiac Ca2+ release channel | Diastolic Ca2+ removal and arrhythmia |
| RYR3 | Ryanodine receptor 3, broadly expressed Ca2+ release channel | Neuronal and smooth muscle Ca2+ signaling |
| ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | Ca2+ release and feedback inactivation |
| ITPR2 | Inositol 1,4,5-trisphosphate receptor type 2 | Exocrine secretion and Ca2+ oscillations |
| ITPR3 | Inositol 1,4,5-trisphosphate receptor type 3 | Immune cell Ca2+ signaling |
| ATP2A1 | SERCA1, sarco/endoplasmic reticulum Ca2+-ATPase 1 | Fast-twitch muscle relaxation |
| ATP2A2 | SERCA2, sarco/endoplasmic reticulum Ca2+-ATPase 2 | Cardiac relaxation and store refilling |
| ATP2B1 | PMCA1, plasma membrane Ca2+-ATPase 1 | Long-term Ca2+ extrusion |
| ATP2B2 | PMCA2, plasma membrane Ca2+-ATPase 2 | Neuronal Ca2+ homeostasis |
| SLC8A1 | NCX1, Na+/Ca2+ exchanger 1 | Cardiac and neuronal Ca2+ extrusion |
| SLC8A2 | NCX2, Na+/Ca2+ exchanger 2 | Brain Ca2+ regulation |
| CALM1 | Calmodulin 1, ubiquitous Ca2+ sensor | Buffering and Ca2+-dependent signaling |
| CALM2 | Calmodulin 2 | Cardiac and neuronal Ca2+ sensing |
| CALM3 | Calmodulin 3 | Regulation of Ca2+ channels and pumps |
| ACTN1 | Alpha-actinin-1, actin crosslinker with calmodulin-like domain | Cytoskeletal Ca2+ binding |
| MCU | Mitochondrial calcium uniporter | Mitochondrial Ca2+ uptake |
| SLC24A1 | NCKX1, Na+/Ca2+-K+ exchanger 1 | Retinal and neuronal Ca2+ extrusion |
How Is negative regulation of cytosolic calcium ion concentration Regulated?
The negative regulation of cytosolic calcium ion concentration is itself tightly regulated. Protein kinases such as PKA and CaMKII phosphorylate SERCA regulators (e.g., phospholamban) and ion channels to modulate Ca2+ removal. Calcium-binding proteins like calmodulin provide Ca2+-dependent feedback that inhibits release channels and activates pumps. Mitochondrial Ca2+ uptake is controlled by the MCU complex and its regulators, which respond to cytosolic Ca2+ levels and energy status. Additionally, store-operated calcium entry, mediated by STIM and ORAI proteins, is suppressed when stores are refilled, indirectly reducing cytosolic Ca2+.
negative regulation of cytosolic calcium ion concentration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RYR2 | Catecholaminergic polymorphic ventricular tachycardia | Knock-in of patient mutation in iPSC-derived cardiomyocytes |
| ATP2A2 | Heart failure, Darier disease | Knockout or point mutation in cardiac cell lines |
| ITPR1 | Spinocerebellar ataxia, Gillespie syndrome | Knockout in neurons or HEK293 cells |
| SLC8A1 | Hypertension, cardiac arrhythmia | Overexpression and knockout in cardiomyocytes |
| CALM1 | Long QT syndrome, CPVT | Point mutation knock-in in iPSC-derived cardiomyocytes |
Cardiovascular disease
Impaired negative regulation of cytosolic Ca2+ in cardiomyocytes contributes to arrhythmias, heart failure, and hypertension. Mutations in RYR2 and ATP2A2 (SERCA2) are linked to catecholaminergic polymorphic ventricular tachycardia and heart failure, respectively [1,2]. Na+/Ca2+ exchanger dysfunction further exacerbates Ca2+ overload.
Neurodegeneration
In neurons, failure to maintain low cytosolic Ca2+ leads to excitotoxicity and cell death, implicated in Alzheimer's disease, Parkinson's disease, and stroke [2,7]. Dysfunctional mitochondria and PMCA pumps contribute to neuronal Ca2+ dyshomeostasis [1,5].
Metabolic and renal disorders
Altered cytosolic Ca2+ regulation in vascular smooth muscle and kidney afferent arterioles affects blood pressure and glomerular filtration. Intracellular Na+ and Ca2+ imbalances are linked to cardiac metabolism and diabetic cardiomyopathy.
From negative regulation of cytosolic calcium ion concentration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene increase cytosolic Ca2+? | CRISPR knockout cell line (e.g., HEK293, HeLa) |
| Does a specific point mutation alter Ca2+ buffering? | Point-mutation knock-in via CRISPR |
| Can a disease-associated variant recapitulate Ca2+ dysregulation? | Knock-in of patient variant in iPSC-derived cells |
| Where does a Ca2+-regulating protein localize? | Tagged knock-in with fluorescent protein |
| Does overexpression of a Ca2+ buffer reduce Ca2+ transients? | Overexpression cell line |
| Which genes regulate cytosolic Ca2+ in a genome-wide manner? | CRISPR library screening with Ca2+ indicator |
How to Study the negative regulation of cytosolic calcium ion concentration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| GCaMP imaging | Cytosolic Ca2+ transients | Live-cell imaging of knockout effects |
| Fura-2 ratiometry | Quantitative cytosolic Ca2+ concentration | Smooth muscle and neuronal Ca2+ studies [3,5] |
| Patch-clamp | Ca2+ currents and membrane potential | Electrophysiology in excitable cells |
| CRISPR screen with Ca2+ reporter | Genes affecting cytosolic Ca2+ | Discovery of novel regulators |
| Western blot | Protein expression of Ca2+ pumps/exchangers | Validation of knockout or overexpression |
| qPCR | mRNA levels of Ca2+-regulating genes | Gene expression analysis |
| Immunofluorescence | Subcellular localization of Ca2+ proteins | Tagged knock-in validation |
| Mitochondrial Ca2+ measurement | Mitochondrial Ca2+ uptake | MCU function studies |
Genetically encoded calcium indicators (GECIs)
GECIs such as GCaMP allow real-time monitoring of cytosolic Ca2+ changes in live cells. They are used to measure the effects of gene knockout or overexpression on Ca2+ transients [4,5].
Calcium imaging with fluorescent dyes
Ratiometric dyes like Fura-2 and Indo-1 provide quantitative measurements of cytosolic Ca2+ concentration. These are widely used in smooth muscle and neuronal studies [3,5].
Patch-clamp electrophysiology
Patch-clamp records Ca2+ currents and membrane potential, indirectly reporting on cytosolic Ca2+ regulation. It is particularly useful in excitable cells.
CRISPR screening with Ca2+ readouts
Genome-wide CRISPR knockout or activation screens coupled with Ca2+-sensitive reporters can identify novel regulators of cytosolic Ca2+ concentration.
How CRISPR Can Be Used to Study GO:0051481 negative regulation of cytosolic calcium ion concentration
Knockout
CRISPR knockout of genes such as ATP2A2, SLC8A1, or ITPR1 can reveal their contribution to cytosolic Ca2+ clearance. Knockout cell lines are generated by inducing frameshift mutations in early exons, followed by functional validation using Ca2+ imaging [4,5].
Point Mutation
Point mutations identified in patients (e.g., in RYR2 or CALM1) can be introduced via CRISPR base editing or homology-directed repair to study their impact on Ca2+ regulation. These models help establish causality of specific variants [2,8].
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci allows real-time tracking of Ca2+-regulating proteins. Knock-in of disease-associated alleles in iPSCs provides patient-relevant models [2,8].
Overexpression
Overexpression of Ca2+ buffers (e.g., calmodulin) or pumps (e.g., SERCA) can enhance negative regulation of cytosolic Ca2+. This is achieved by lentiviral transduction or CRISPR activation [1,5].
How EDITGENE Supports negative regulation of cytosolic calcium ion concentration Research
Researchers studying negative regulation of cytosolic calcium ion concentration-related genes often need to determine whether a candidate gene is causally involved in Ca2+ homeostasis or is merely correlated. This requires precise genetic models that can isolate the gene's function without confounding artifacts.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of cytosolic calcium ion concentration research.
Frequently Asked Questions About negative regulation of cytosolic calcium ion concentration
What is GO:0051481?
GO:0051481 is a Gene Ontology biological process term defined as any process that decreases the concentration of calcium ions in the cytosol [1,2].
What genes are involved in negative regulation of cytosolic calcium ion concentration?
Key genes include RYR1, RYR2, RYR3, ITPR1, ITPR2, ITPR3, ATP2A1, ATP2A2, ATP2B1, ATP2B2, SLC8A1, SLC8A2, CALM1, CALM2, CALM3, and MCU [1,2,4,5,8].
How does the cell lower cytosolic calcium?
Cells lower cytosolic Ca2+ by buffering with calcium-binding proteins, sequestering Ca2+ into the endoplasmic reticulum and mitochondria, and extruding Ca2+ across the plasma membrane via pumps and exchangers [1,2,5].
Why is negative regulation of cytosolic calcium important?
It prevents cytotoxic Ca2+ overload, terminates Ca2+ signals, and allows repeated rounds of Ca2+-dependent processes such as muscle contraction and secretion [1,2,5].
What diseases are linked to defective cytosolic calcium regulation?
Cardiovascular diseases (arrhythmias, heart failure), neurodegeneration (Alzheimer's, Parkinson's), and metabolic disorders [1,2,3,7].
What methods are used to study cytosolic calcium regulation?
Methods include GCaMP imaging, Fura-2 ratiometry, patch-clamp, CRISPR screens, and mitochondrial Ca2+ measurements [3,4,5,6,7].
How can CRISPR help study cytosolic calcium regulation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes to test their role in Ca2+ homeostasis [2,4,6,8].
What is the role of SERCA in cytosolic calcium regulation?
SERCA pumps transport Ca2+ from the cytosol into the endoplasmic reticulum, lowering cytosolic Ca2+ and refilling stores [1,4,5].
What is the role of mitochondria in cytosolic calcium regulation?
Mitochondria take up Ca2+ via the MCU complex, acting as a buffer to reduce cytosolic Ca2+ transients [1,2].
How does calmodulin contribute to negative regulation of cytosolic calcium?
Calmodulin binds free Ca2+, buffering it, and also regulates Ca2+ channels and pumps in a Ca2+-dependent manner.
Conclusion
GO:0051481, negative regulation of cytosolic calcium ion concentration, is a fundamental biological process that safeguards cells against Ca2+ overload and shapes Ca2+ signaling. Understanding its molecular players and regulatory mechanisms is essential for deciphering normal physiology and disease. CRISPR-based models and advanced imaging techniques continue to illuminate this process, offering new therapeutic opportunities.
References
- 1. Bay J et al.. 2013. Intracellular Na⁺ and cardiac metabolism.. J Mol Cell Cardiol 61:20-7 PMID: 23727097
- 2. Yamaguchi N. 2020. Molecular Insights into Calcium Dependent Regulation of Ryanodine Receptor Calcium Release Channels.. Adv Exp Med Biol 1131:321-336 PMID: 31646516
- 3. Scholz H et al.. 1995. Differential regulation of cytosolic calcium between afferent arteriol ar smooth muscle cells from mouse kidney.. Pflugers Arch 431(1):46-51 PMID: 8584417
- 4. Arige V et al.. 2022. Functional determination of calcium-binding sites required for the activation of inositol 1,4,5-trisphosphate receptors.. Proc Natl Acad Sci U S A 119(39):e2209267119 PMID: 36122240
- 5. Kamishima T et al.. 1997. Regulation of the cytosolic Ca2+ concentration by Ca2+ stores in single smooth muscle cells from rat cerebral arteries.. J Physiol 501 ( Pt 3)(Pt 3):497-508 PMID: 9218210
- 6. Navarrete KM et al.. 2023. BopN is a Gatekeeper of the Bordetella Type III Secretion System.. Microbiol Spectr 11(3):e0411222 PMID: 37036369
- 7. Van Goor F et al.. 1999. Coordinate regulation of gonadotropin-releasing hormone neuronal firing patterns by cytosolic calcium and store depletion.. Proc Natl Acad Sci U S A 96(7):4101-6 PMID: 10097170
- 8. Drmota Prebil S et al.. 2016. Structure and calcium-binding studies of calmodulin-like domain of human non-muscle α-actinin-1.. Sci Rep 6:27383 PMID: 27272015
